What does a Bard PowerPort mass tort marketing campaign include?

A Bard PowerPort mass tort marketing campaign from Mass Tort Marketing Agency covers channel strategy across Meta, Google/PPC, OTT, and mass tort SEO; compliant ad creative; TCPA-verified intake; claimant qualification against your Bard PowerPort case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.

Are Bard PowerPort leads exclusive to my firm?

Yes. Every Bard PowerPort lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.

How are Bard PowerPort claimants qualified before delivery?

Each Bard PowerPort claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a TrustedForm or Jornaya consent token captured under the FCC one-to-one consent standard before the lead reaches your intake team.

How is a Bard PowerPort campaign priced?

Campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. You can scale volume up or down by tort as your docket capacity changes.

Do Bard PowerPort campaigns screen for SVC syndrome after a port revision?

Yes. Superior vena cava (SVC) syndrome following catheter migration or a port revision is among the complication patterns our intake team screens for on Bard PowerPort campaigns. Screening verifies the device history, the documented complication, and the treating-provider records before a claimant is delivered to your firm — the firm makes the final eligibility determination.

Bard PowerPort Leads

Connect with patients who experienced device fracture, migration, embolism, or serious infection from Bard PowerPort implantable port catheter devices.

Start Your Campaign

Bard PowerPort Device Litigation

The Bard PowerPort is an implantable port catheter device used to deliver medications, fluids, and blood products directly into the bloodstream, commonly used by cancer patients undergoing chemotherapy. Reports indicate these devices are prone to fracture, catheter migration, and other mechanical failures that can lead to life-threatening complications including pulmonary embolism. Lawsuits allege Bard (now part of BD) manufactured defective devices and failed to warn about the risks of device failure.

Associated Conditions

Device fracture and catheter breakage
Catheter migration to the heart or lungs
Pulmonary embolism
Infection at the port site or bloodstream
Blood clots and deep vein thrombosis
Cardiac arrhythmia or perforation
Need for surgical removal or revision

Claimant Eligibility

Had a Bard PowerPort device implanted
Experienced device fracture, migration, or mechanical failure
Required emergency surgery or hospitalization due to device complications
Diagnosed with embolism, infection, or thrombosis related to the device
Medical records documenting the device implantation and complications

Why Law Firms Choose Us

Exclusive Leads

Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.

Pre-Qualified Claimants

Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.

Live Transfer

Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.

Running a Bard PowerPort mass tort marketing campaign

Common questions from law firms about Bard PowerPort lead generation and campaign management.

What does a Bard PowerPort mass tort marketing campaign include?: A Bard PowerPort mass tort marketing campaign from Mass Tort Marketing Agency covers channel strategy across Meta, Google/PPC, OTT, and mass tort SEO; compliant ad creative; TCPA-verified intake; claimant qualification against your Bard PowerPort case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
Are Bard PowerPort leads exclusive to my firm?: Yes. Every Bard PowerPort lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
How are Bard PowerPort claimants qualified before delivery?: Each Bard PowerPort claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a TrustedForm or Jornaya consent token captured under the FCC one-to-one consent standard before the lead reaches your intake team.
How is a Bard PowerPort campaign priced?: Campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. You can scale volume up or down by tort as your docket capacity changes.
Do Bard PowerPort campaigns screen for SVC syndrome after a port revision?: Yes. Superior vena cava (SVC) syndrome following catheter migration or a port revision is among the complication patterns our intake team screens for on Bard PowerPort campaigns. Screening verifies the device history, the documented complication, and the treating-provider records before a claimant is delivered to your firm — the firm makes the final eligibility determination.

See how every lead is qualified on our mass tort leads page, or compare providers in our top mass tort marketing firms guide.